Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12173087
Melanocortin 1 receptor ligands and methods of use
granted -
US 12171768
IRAK4 degraders and uses thereof
granted -
US 12173314
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12174192
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 12172038
Anti-coronavirus antibodies and methods of use
granted -
US 12171818
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted -
US 12171760
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
granted -
US 12171765
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12173317
Use of histone modifiers to reprogram effector T cells
granted -
US 12172994
Pyrimidine compound as JAK kinase inhibitor
granted -
US 12173337
Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 12171758
Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto
granted -
US 12171785
Pluripotent cells derived from bone marrow and methods for isolation
granted -
US 12173088
Anti-microbial peptides
granted -
US 12173084
Phosphorylated dicer antibody and methods of use thereof
granted -
US 12171864
Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method
granted -
US 12171750
Isoxazoline parasiticide formulations and methods for treating blepharitis
granted -
US 12173274
Enhanced immune effector cells and use thereof
granted -
US 12171741
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12171786
Use of mesenchymal stem cells for the treatment of inflammation
granted -
IT 202300012522
FLUOROMETIL-CARNITINA PER USO COME INIBITORE DI COLINA TRIMETILAMMINA (TMA) LIASI.
granted -
WO 2024259178
INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE 3 ET LEURS UTILISATIONS
granted -
US 12168767
Modified double-stranded RNA agents
granted -
US 12168692
Antibodies targeting CCR2
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.